Viewing Study NCT06484920


Ignite Creation Date: 2025-12-25 @ 4:23 AM
Ignite Modification Date: 2026-02-01 @ 11:21 PM
Study NCT ID: NCT06484920
Status: RECRUITING
Last Update Posted: 2025-02-03
First Post: 2024-06-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL
Sponsor: Rita Assi
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed Hodgkin Lymphoma View
None Refractory Hodgkin Lymphoma View
None Relapsed Non-Hodgkin Lymphoma View
None Refractory Non-Hodgkin Lymphoma View
None B-cell Lymphoma View
Keywords: